Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Search Posts
Washington Times
Questionable Motives Behind Supplement Bill
Washington Times
Medical Magellans
Food and Drug Administration (FDA) rules are supposedly intended to ensure the safety and efficacy of new drugs and medical devices. It is FDA’s technology…
Products
Gregory Conko Discussing Cloning Translating Into Big Business and Safety Issues on CNNfn
CNNfn: Money & Markets (c) 2003 Federal Document Clearing House. All Rights Reserved. Friday, October 31, 2003 Business Cloning Translating Into Big Business and Safety…
Study
Safety, risk and the precautionary principle: rethinking precautionary approaches to the regulation of transgenic plants
Full Document Available in PDF Ever since completion of the Cartagena Protocol on Biosafety in…
Legal Brief
Memorandum Opinion in Association of Physicians and Surgeons vs US FDA
Comment
Comments Regarding the Constitutionality of FDA Treatment of Product Information
This request for comments represents a welcome departure from FDA’s prior treatment of First Amendment concerns in the context of product advertising, labeling, and promotions.